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Summary
Mounting evidence implicates chronic oxidative stress as a critical driver of the
aging process. Down syndrome (DS) is characterized by a complex phenotype,
including early senescence. DS cells display increased levels of reactive oxygen spe-
cies (ROS) and mitochondrial structural and metabolic dysfunction, which are coun-
terbalanced by sustained Nrf2‐mediated transcription of cellular antioxidant
response elements (ARE). Here, we show that caspase 3/PKCδdependent activation
of the Nrf2 pathway in DS and Dp16 (a mouse model of DS) cells is necessary to
protect against chronic oxidative damage and to preserve cellular functionality.
Mitochondria‐targeted catalase (mCAT) significantly reduced oxidative stress,
restored mitochondrial structure and function, normalized replicative and wound
healing capacity, and rendered the Nrf2‐mediated antioxidant response dispensable.
These results highlight the critical role of Nrf2/ARE in the maintenance of DS cell
homeostasis and validate mitochondrial‐specific interventions as a key aspect of
antioxidant and antiaging therapies.
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1 | INTRODUCTION
Down syndrome (DS), caused by the presence of an extra copy of
human chromosome 21 (Hsa21), is characterized by a complex
clinical phenotype that includes developmental alterations, intellec-
tual disability and accelerated aging (Roizen & Patterson, 2003). An
expanding number of studies have reported the presence of chronic
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oxidative stress and mitochondrial dysfunction in DS at both the cel-
lular and organismal levels (Annerén & Epstein, 1987; Busciglio &
Yankner, 1995; Antonarakis et al., 2004; Lott & Dierssen, 2012;
Campos et al., 2011). Recently, we reported that decreased mito-
chondrial activity, increased ROS and mitochondrial fragmentation in
DS cells are associated with transcriptional activation of the nuclear
factor (erythroid‐derived 2)‐like 2 (Nrf2) signaling pathway (Helguera
et al., 2013). Nrf2, a master regulator of antioxidant response ele-
ments (ARE), is a cytoplasmic protein constitutively synthesized and
rapidly degraded after ubiquination mediated by its repressor, Kelch
like‐ECH‐associated protein 1 (Keap1)(Itoh et al., 1999; Nguyen
et al., 2009; Zhang et al., 2004). Under oxidative conditions, the cys-
teine‐rich interacting domain in Keap1 changes its conformation, dis-
abling its default association with Nrf2. As a result, Nrf2
accumulates in the cytoplasm and after phosphorylation by PKCδ,
pNrf2ser40 translocates into the nucleus where it activates tran-
scription of antioxidant response elements (ARE) (Niture et al., 2009;
Villeneuve et al., 2010; Zhang & Hannink, 2003).
The “Free Radical Theory of Aging” (Harman, 1956) postulates
a link between the progressive accumulation of macromolecular
damage caused by reactive oxygen species (ROS) and the aging
process, particularly cell arrest in mitotic cells, referred to as cellu-
lar senescence. The main source of ROS generation inside cells are
electrons released from the mitochondrial electron transport chain
that reduce molecular oxygen to form superoxide anions (O2
•−),
which in turn are converted to hydrogen peroxide (H2O2) that gen-
erate reactive hydroxyl radicals (•OH) unless H2O2 is inactivated
by glutathione peroxidase or peroxisomal catalase. The impact of
ROS accumulation in mammalian lifespan was directly tested in a
transgenic mouse overexpressing human catalase with a mitochon-
drial targeting sequence (mCAT) (Schriner, 2005). mCAT expression
resulted in increased longevity without interference on major trans-
duction pathways. Life span extension in mCAT mice was associ-
ated with reduced cardiac pathology, decreased DNA oxidative
damage, protection against age‐related insulin resistance, and
improved proteostasis, underscoring the role of cumulative oxida-
tive damage in aging associated pathologies (Lee et al., 2010; Mao
et al., 2012; Treuting et al., 2008; Umanskaya et al., 2014). To fur-
ther understand the role of Nrf2 stabilization in homeostasis and
survival of trisomic cells, we assessed the Nrf2 signaling pathway
as well as the effect of mCAT in DS human fibroblasts (HF), and
mouse embryonic fibroblasts (MEF) derived from Dp16 mice, a
segmentally trisomic model that reproduces several clinical pheno-
types present in people with DS, including cognitive impairment
(Belichenko et al., 2015; Li et al., 2007; Yu et al., 2010). We found
that chronic canonical Nrf2 activation is required to prevent exten-
sive oxidative damage and is critical for survival of both DS HF
and Dp16 MEF. mCAT expression reverted mitochondrial dysfunc-
tion and reduced ROS levels leading to the inactivation of Nrf2
stabilization and translocation. Thus, Nrf2 is required in trisomic
cells to maintain viability and cellular function. However, its activity
can be rendered dispensable by an effective mitochondrial‐targeted
intervention.
2 | RESULTS
2.1 | Oxidative stress and mitochondrial
dysfunction in DS HF and Dp16 MEF
We recently reported chronic downregulation of mitochondrial activ-
ity in DS cells as an adaptive response to minimize oxidative damage
and preserve basic cellular functions (Busciglio et al., 2002; Helguera
et al., 2013). We further examined mitochondrial function and struc-
ture in DS HF and Dp16 MEF. As the mitochondrial network is the
main source of cellular ROS (Balaban et al., 2005) mitochondrial ROS
were quantified with a radiometric biosensor (mitoHyPer) that
detects peroxide intermediates in the organelle (see methods). Cellu-
lar ROS, mitochondrial membrane potential (MMP) and network
integrity were also assessed to establish the putative correlation
between ROS levels and mitochondrial deficits. Consistent with our
previous findings, DS cells exhibited both significantly higher mito-
HyPer fluorescence ratio (Figure 1a), and increased dichlorofluores-
cein (DCF) signal (Figure 1b), indicative of oxidative stress. Increased
DCF was also evident in Dp16 cells (Figure 1c, Supporting Informa-
tion Figure S4C). Mitochondria are organized as dynamic networks
of interconnected branched tubules of different lengths and shape,
reflecting the organelle functionality (Friedman & Nunnari, 2014). As
chronic oxidative stress in trisomic cells results in morphological
changes in the mitochondrial network (Helguera et al., 2013), we
asked whether structural changes could be tracked in DS HF and
Dp16 MEF. Mitochondria were visualized using mitochondria‐tar-
geted yellow fluorescent protein (mitoYFP). To analyze structural
variations in mitochondrial networks we applied a recently devel-
oped computational tool that establishes a correlation between the
level of fragmentation/branching and the mean degree of connectiv-
ity at every point of the network, referred as mean degree value
(MDV; Zamponi et al., 2018; see methods; Supporting Information
Figure S3). A fragmented mitochondrial network was detected in DS
HF (Figure 1d, insets) as illustrated by a lower MDV compared to
control diploid human fibroblasts (NL) (Figure 1d), and also in Dp16
MEF (Figure 1e; Supporting Information Figure S4D), albeit to a les-
ser extent. Wild‐type (WT) MEF treated with 200 μM paraquat (PQ)
(Lang et al., 2010; Magnone et al., 2014) for 48 hr were included in
the analysis as a positive control of network fragmentation. Consis-
tent with the alterations described above, the MMP was decreased
in DS cells (Figure 1f).
To evaluate the contribution of mitochondrial oxidative stress
to abnormal cellular function and the effect of a mitochondrial‐tar-
geted intervention in trisomic cells, we transduced mCAT using a
lentiviral system (pLV‐eGFP; (Enomoto et al. 2013); see also meth-
ods). CAT expression vectors were designed either with a complex
IV subunit‐targeting sequence to direct the protein to the mito-
chondrial matrix (mCAT), or without targeting sequence for cyto-
plasmic expression (cCAT; Figure 1g). Both constructs rendered a
protein of correct molecular weight, displayed enzymatic activity,
and compartmentalized correctly, as observed by immunocyto-
chemistry and western blot of cytoplasmic‐ and mitochondrial‐
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enriched fractions (Supporting Information Figure S1A–D). The
ability of mCAT and cCAT to protect against chronic mitochondrial
oxidative stress was assayed by treating mCAT‐ or cCAT‐express-
ing HEK cells with 5 mM PQ for 48 hr (Supporting Information
Figure S2B). PQ diverts electrons out from Complex I of the elec-
tron transport chain generating ROS in the mitochondrial compart-
ment (Cochemé & Murphy, 2008). Both CAT constructs prevented
PQ‐induced cell death (Figure 1h) and diminished oxidative dam-
age (Supporting Information Figure S2). However, mCAT was
effective in recovering MMP (Figure 1i, Supporting Information
Figure S1F), and provided better protection against mitochondrial
ROS (Supporting Information Figure S1E). mCAT was also appro-
priately transduced in DS HF, minimizing ROS accumulation,
restoring mitochondrial structure and significantly improving MMP
(Figures 1 and 3a). A similar mCAT antioxidant protective effect
was observed when expressed in Dp16 MEF (Supporting Informa-
tion Figure S4A–C).
2.2 | mCAT normalizes proliferation and wound
healing capacity of DS HF
Previous work showed that multiple cellular functions are sensitive
to mitochondrial failure in DS cells (Coskun et al., 2016; Helguera
et al., 2013). To assess the potential functional recovery afforded
by mCAT, we analyzed cellular proliferation and motility in a
wound‐healing assay. First, we asked whether ROS‐associated
mitochondrial dysfunction interferes with cell repopulation after
in vitro injury and, if so, whether mCAT expression can prevent it.
We checked wound healing sensitivity to oxidative stress in HEK
cells by injuring confluent cultures and treating them with 5 mM
PQ. Wound area closure was visualized by time‐lapse microscopy
as described in the methods section. PQ delayed the wound heal-
ing process, which was significant 14–16 hr postwound. These
functional deficits were prevented by mCAT expression (Fig-
ure 2a).
We then examined wound healing in DS HF expressing eYFP to
facilitate live cell imaging. A delay in wound closure was evident in
DS cultures when compared to NL cells 30 hr postwound (Figure 2b).
Quantification of the number of cells repopulating the wound gap
42 hr postwound showed a reduction in DS HF covered area and
density (Figure 2c,d), while mCAT expression in these cells signifi-
cantly improved all three parameters (Figure 2b–d).
2.3 | Canonical Nrf2 stabilization via PKCδ and
caspase 3 is critical for maintaining DS cellular
function
Transcriptome analysis showed an Nrf2‐associated antioxidant
response in DS cells (Helguera et al., 2013). Consistent with the
notion that accumulation of Nrf2 is indicative of cells under stress
adjusting to neutralize oxidative damage (Niture et al., 2014; Zhang
et al., 2004), we found a marked increase in Nrf2 protein levels in
DS HF and Dp16 MEF cellular homogenates (Figure 3a,c) (probed
with SC722 antibody, see Methods, Supporting Information Figures
S5A–C and S7B,C) and strong immunofluorescent signal for
pNrf2ser40 (pNrf2) in the nuclei of DS cells (see Methods, Fig-
ure 3b; Supporting Information Figures S64A and S7D,E), consistent
with the presence of chronic oxidative stress. Transcriptional upreg-
ulation of Nrf2‐dependent antioxidant response elements (ARE) was
confirmed by qPCR (Supporting Information Figure S8). PKCδ levels
were similar in NL and DS cells (Figure 3d). To evaluate whether
Nrf2 phosphorylation in DS cells is dependent on PKCδ kinase
activity (Niture et al., 2009), we used the PKCδ inhibitor Gö6983
and also Gö6976, an inhibitor that do not affect PKCδ but interfere
PKCα and PKCβ isoforms instead (Gschwendt et al., 1996; Martiny‐
Baron et al., 1993; Stempka et al., 1999). Treatment with Gö6983
prevented pNrf2 nuclear translocation in both basal conditions and
after PQ treatment, while Gö6976 had no effect (Figure 3e). As
PKCδ can be activated by caspase 3 (Casp3) cleavage (Anantharam
et al., 2002), we incubated PQ‐treated DS HF with the Casp3‐
specific inhibitor Z‐DEVD‐FMK for 12 hr, preventing Nrf2 nuclear
translocation (Figure 3e). To establish the relevance of Nrf2 activa-
tion for DS cell function, we measured oxidative damage after
Gö6983 inhibition of Nrf2 phoshporylation and nuclear transloca-
tion. Under these conditions, DS HF proliferation decreased, associ-
ated with a significant burst in cellular ROS, (Figure 4a,b). mCAT
significantly reduced Nrf2 levels in both DS HF and Dp16 MEF
(Figure 3a,c), as well as its phosphorylation and nuclear transloca-
tion (Figure 3b,d). Furthermore, mCAT reversed Nrf2 nuclear
translocation in DS HF treated with 200 μM PQ for 24 hr, where
the additive effects of trisomy and PQ resulted in a dramatic
increase in nuclear pNrf2 levels (Figure 3e). Not surprisingly, other
antioxidants targeted to mitochondria, specifically MitoQ (1 μM)
and MitoTEMPO (20 μM) also induced Nrf2 deactivation/degrada-
tion in DS HF (Supporting Information Figure S5D). Finally, we
tested whether an antioxidant intervention (mCAT) would amelio-
rate the senescent phenotype present in DS HF, including increased
cell size, a well‐characterized early marker of cellular senescence
(Hayflick, 1965; Phillip et al., 2017; Rodier & Campisi, 2011). DS
HF displayed significantly reduced proliferation (Figure 4c) and lar-
ger average cell area (Figure 4d). Both parameters were partially
reversed by mCAT expression, restoring the proliferative capacity
of DS cells. Together, as summarized in Figure 5, the above results
indicate that Nrf2 nuclear translocation in DS is mediated by
casp3‐activated PKCδ phosphorylation, which is critical to maintain
cell homeostasis (Figure 5, left panel). mCAT expression reduced
oxidative stress in DS HF, leading to a recovery in cellular metabo-
lism and to the inactivation of Nrf2 stabilization (Figure 5, right
panel).
3 | DISCUSSION
As postulated by Harman in 1956, oxidative damage, mainly caused
by mitochondria‐generated ROS, leads to limited cellular metabolic
function and viability, and compromise both organismic perfor-
mance and life span (Harman, 1956). Alterations in chromosome
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number, particularly trisomy 21, have been associated with elevated
mitochondrial ROS, oxidative damage, diminished metabolism, and
compromised resilience (Busciglio & Yankner, 1995; Coskun et al.,
2016; Slonim et al., 2009; Zis et al., 2012) Here, we show that
human DS HF and mouse Dp16 MEF display compromised mito-
chondrial function, oxidative stress, and activated Nrf2 antioxidant
response. Furthermore, our results demonstrate that sustained Nrf2
stabilization is vital to maintain cell function in both DS and Dp16.
Previous results showed that metabolic recovery in DS cells can be
achieved by combined treatment with antioxidants and creatine
(Helguera et al., 2013). In agreement with this notion, reduction in
mitochondrial ROS by mCAT led to restoration of MMP and nor-
malization of the mitochondrial network in DS cells. Most impor-
tantly, mCAT deactivated Nrf2 stabilization, as DS HF treated with
mCAT exhibited lower Nrf2 levels similar to NL cells. The localiza-
tion of mCAT in the mitochondrial matrix appears to be critical to
exert its beneficial effect (Schriner, 2005). In that sense, treatment
of DS cultures with the mitochondrial‐targeted antioxidants MitoQ
and MitoTEMPO had a similar effect, decreasing Nrf2 stabilization
(Supporting Information Figure S5D), underscoring the therapeutic
potential of optimized antioxidant mitochondrial‐specific interven-
tions.
A similar protective effect was achieved by cCAT expression in
PQ stressed cells, but it failed to recover MMP (Figure 1h, i; Sup-
porting Information Figure S2). However, in agreement with previous
reports (Bai et al., 1999), cCAT protein displayed a better perfor-
mance preventing H2O2 ‐mediated damage (Supporting Information
Figure S2C). While PQ‐induced ROS are generated by electrons from
respiratory Complex I, inside the mitochondrial matrix, treatment
with H2O2 exposes the cell to exogenous ROS, which explains the
differential effects of mCAT and cCAT (Supporting Information Fig-
ure S2A).
Oxidative stress in DS has been linked to particular proteins
encoded by genes located in Hsa21 that are overexpressed or whose
activity is deregulated, namely superoxide dismutase 1 (SOD1), the
regulatory kinase Dyrk 1A (DYRK1A), the transcription factor Ets‐2,
or the amyloid precursor protein (APP); all of which are directly or
indirectly inducers of ROS (Busciglio et al., 2002; Rodríguez‐Sureda
et al., 2015; Wolvetang et al., 2003). From a broader perspective,
transcriptome studies in DS revealed multiple extra Hsa21 deregu-
lated genes and activated pathways (Bosman et al., 2015). These
alterations are associated with a specific transcriptional fingerprint of
DS involving mostly genes located outside the supernumerary chro-
mosome, e.g. secondary dysregulations on disomic genes (FitzPatrick,
2005).
Notably, both transcriptional and phenotypic alterations are reca-
pitulated in DS mouse models (Guedj et al., 2016). The Dp16 seg-
mental trisomy carries Hsa21 syntenic fragments, and, unlike the
Ts65Dn mouse model, does not include nonsyntenic Hsa21 genes (Li
et al., 2007).
In a previous report, in‐silico analysis revealed activation of the
Nfr2 pathway in DS astrocytes (Helguera et al., 2013). Here we
expand those results and show stabilization and accumulation of
Nrf2 protein essential for cell survival in both DS HF and Dp16
MEF. Interestingly, we have observed the stabilization of cytoplas-
mic Nrf2 in other human aneuploidies (unpublished results) in
accord with the notion that gene dosage imbalances result in cellu-
lar metabolic stress regardless of the chromosomes involved (Shelt-
zer et al., 2012). The activation of Nrf2 is consistent with the
presence of chronic oxidative stress (Nguyen et al., 2009; Zhang &
F IGURE 1 Oxidative stress and mitochondrial dysfunction in DS HF and Dp16 MEF and antioxidant and cytoprotective effects of catalase.
(a) Quantification of mitochondrial H2O2 in NL and DS HF using the mitoHyPer radiometric sensor. Cultures expressing mCAT and
nonexpressing controls were transfected with mitoHyPer for 48 hr and then fixed. ROS concentration was calculated as the ratio between 488
and 405 nm fluorescence values for each pixel. Heat bar: Yellow and blue indicate highest and lowest ROS levels respectively. Quantification
of the ratio between fluorescence intensity at 488 and 405 nm shows a marked increase in DS cells, which is prevented by mCAT expression.
Heat bar: Yellow indicates highest and blue lowest ROS levels. *p < 0.05. Scale bar = 20 μm. (b) Total ROS levels were measured using DCF in
native and transduced NL and DS HF (NL, DS, NL mCAT and DS mCAT). Quantification shows a significant increase in DCF levels in DS,
which is prevented by mCAT (DS mCAT). *p < 0.05. Scale bar = 20 μm. (c) Quantification of DCF intensity as a measure of total cellular ROS
show a increase on DS mouse model Dp16 MEF (Dp16) compared to control (WT EV), which is prevented in cells expressing mCAT (Dp16
mCAT). *p < 0.05. (d) Mitochondrial network integrity was analyzed in NL and DS HF coexpressing mitochondrial targeted YFP (mitoYFP); in
the same set of conditions described above, using nodes mean degree value (MDV) as parameter of morphological integrity (see methods).
Alexa‐546 phalloidin was used to highlight cell boundaries. Significant fragmentation in DS mitochondrial network is recovered by mCAT.
*p < 0.05. Scale bar = 20 μm. (e) Mitochondrial network quantification analysis in WT and Dp16 MEF cotransduced with EV or mCAT and
mitoYFP. WT EV and WT mCAT cultures were treated with 200 mM PQ for 48 hr to induce mitochondrial stress, as positive control. MDV
values showed more fragmented network structure in Dp16 and in PQ treated WT cells, that were recovered by mCAT. *p < 0.05. (f) MMP
was measured using TMRM as described in Methods in NL and DS HF (NL, DS, NL mCAT, and DS mCAT). mCAT expression significantly
increased MMP in DS cells. Scale bar = 20 μm. (g) Lentiviral plasmids scheme showing the promoter (CAG) and the human catalase sequence
(hcat) in cytoplasmic catalase (cCAT) vector, or hcat attached to a mitochondrial targeting sequence (mts) in the mCAT construct. Control
empty vector (EV) lacks coding sequences. (h) Oxidative stress‐induced cell death was assayed using propidium iodide (PI). Cultures expressing
EV, mCAT or cCAT were treated with 5 mM PQ or vehicle for 0, 24, 48 and 72 hr and then incubated with 1.5 μM PI. Cell death was
quantified as the ratio of PI‐positive nuclei over total nuclei stained with DAPI. (i) Mitochondrial membrane potential (MMP) analyzed with
TMRM probe. Cells expressing EV, mCAT or cCAT were treated 48 hr with 5 mM PQ or vehicle; then incubated with TMRM and measured by
live‐imaging. There is a significant recovery of MMP in PQ‐treated cultures expressing mCAT. Scale bar = 10 μm. *p < 0.05. a, b, c, d, e, and f:
For each experimental condition a total of 20–30 cells were included in the analysis; h and i: six culture replicates (four 10× fields each)
analyzed per condition
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Hannink, 2003) and emphasizes its key role in activating cellular
antioxidant pathways which are critical to curtail oxidative damage.
In this regard, mutations in progerin contribute to oxidative dam-
age and accelerated senescence by blocking Nrf2 nuclear transloca-
tion and therefore increasing cellular vulnerability (Kubben et al.,
2016).
Nrf2 stabilization in DS cells depends on its phosphorylation by
PKCδ, which in turn is activated by casp3, as shown by specific inhi-
bitor assays (Niture et al., 2014), demonstrating the increasingly
complex role of caspases in physiological and cytoprotective signal-
ing pathways beyond their well‐characterized role in apoptosis
(Unsain & Barker, 2015). Alternative and sometimes complementary
antioxidant pathways mediated by p53 and FOXO have been
described in the context of more stringent oxidative conditions (Gor-
rini et al., 2013). In the case of DS cells, p53 activation is associated
with an oxidative stress‐dependent mitochondrial death pathway
(Wolvetang et al., 2003, Helguera et al., 2005), emphasizing the
delicate balance between cytoprotective and pro‐death signals that
are required to maintain cell and organismal viability. Consistent with
this view, we observed significantly higher frequency of p53 translo-
cation events in DS HF only when subjected to PQ treatment (Sup-
porting Information Figure S6C).
Since metabolic alterations observed in DS HF were closely reca-
pitulated in Dp16 MEF, Dp16 appears to be a viable model to inves-
tigate the contribution of mitochondrial deficits to DS‐related
phenotypic alterations at the organismal level.
In summary, this study highlights the contribution of mitochon-
drial oxidative stress to cell dysfunction in trisomy 21 and the key
role of Nrf2 stabilization in DS cell homeostasis. Our data on
Dp16 cells shows the suitability of this DS model to further test-
ing mitochondria‐targeted antioxidant compounds. The fact that
mCAT expression is sufficient for the reversal of redox sensitive
Nrf2 stabilization highlights its effectiveness as an antioxidant and
underscores the relevance of mitochondrial therapies to preserve
F IGURE 2 Restoration of cellular functional capacity by mCAT. (a) HEK293 cells expressing EV or mCAT where seeded and grown on a
gridded glass bottom dish until confluence was reached, treated with 5 mM PQ or vehicle and subjected to a wound healing assay (see
Methods). The quantification of cell‐free area over time (0, 2, 4, 6, 8, 10, 12, 14, 16 and 24 hr) indicates the cells’ competence to repopulate
the cleared area. mCAT markedly reduces PQ‐induced delay in wound healing in HEK293 cells. Scale bar: 100 μm. (b) DS fibroblast were co‐
transduced with either EV or mCAT and a plasmid encoding cytoplasmic eYFP, seeded on a grid‐containing coverslip and subjected to wound
healing assay. Images were taken 0, 6, 18 and 30 hr after injury. Scale bar = 50 μm. Chart: Quantification shows the migration distance of NL
EV, DS EV and DS mCAT fibroblasts 30 hr after injury. *p < 0.05. (c) Cell‐covered area was quantified in DS cultures expressing EV or mCAT
at 0 and 42 hr after injury. The red line indicates the surface of the grid area. (d) The number of cells within the grid at 42 hr was quantified
using DAPI staining. *p < 0.05. a, b, c and d: at least three IVIDI gridded glass bottom dishes, with four independent quadrants each, were
processed for each experimental condition
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viability and recover cellular function in DS and possibly other
clinical conditions where energy metabolism is compromised.
4 | EXPERIMENTAL PROCEDURES
4.1 | Cell culture
MEF were obtained from C57BL6 wild‐type and DP16 (Yu et al.,
2010) mice, as described (Xu, 2005). MEF and HEK293 cells were cul-
tured in DMEM (Gibco, Life technologies) supplemented with 10%
FBS (Natocord), 1% Glutamax and nonessential amino acids (Gibco,
Life technologies), in a 5% CO2 and 37°C atmosphere. HF from four
diploid (NL) subjects and four matched subjects with DS were pro-
cured from Coriell Institute Cell Repository and cultured according to
the provider's specifications (https://catalog.coriell.org/). All the
experiments involving animal manipulations were carried out accord-
ing to the guidelines established by the Institutional Animal Care and
Use Committee (IACUC) of the University of California‐Irvine.
4.2 | Expression vectors
mCAT sequence was provided by Samuel Schriner (Irvine, CA, USA)
and subcloned into a lentiviral vector pLV‐eGFP kindly provided by
Dr. Pantelis Tsoulfas (Addgene plasmid # 36083). Two sets of for-
ward primers were used to generate both catalase‐carrying plasmids,
one including the mitochondrial targeting sequence (MTS) of the
original mCAT vector (mCAT) and other excluding the MTS for cyto-
plasmic expression (cCAT). The mitochondrial‐targeted YFP plasmid
was purchased from OriGene and the ORF subcloned into the same
pLenti vector (mitoYFP).
4.3 | shRNA silencing vector
The short hairpin RNA (shRNA) plasmid was constructed in pSilencer
1.0‐U6 vector (Xia et al., 2003) GGGAGGAGCTATTATCCATTC was
used as targeting sequence (Supporting Information Figure S7A). The
DNA fragments containing U6‐PKD1‐si and U6‐control‐si were
F IGURE 3 Activation of the Nrf2 signaling pathway in DS and Dp16 cells. (a) WB analysis of total NRF2 levels in NL and DS cultures
infected with EV or mCAT. Samples were probed against total NRF2 and CAT. ATP5α and Tub protein levels were used as loading controls. (b)
Immunofluorescence against active pNRF2ser40 (green) performed in NL and DS cultures expressing EV or mCAT. Nuclei were stained with
DAPI. pNRF2 nuclear localization were considered positive when nuclear over cytoplasmic fluorescence intensity ratio was greater than 1.
White arrow: no translocation; Red arrowheads: NRF2‐positive nuclei. Scale bar = 20 μm. (c) Total NRF2 levels were visualized by western blot
of WT and DP16 cultures expressing EV or mCAT. Note the marked reduction of Nrf2 levels in Dp16 fibroblasts expressing mCAT. (d) PKCδ
protein levels by wb in NL and DS fibroblasts infected with EV or mCAT. PKCδ expression did not change on analyzed samples. (e) Increased
pNRF2 nuclear translocation in DS cells. PKCδ is activated by caspase 3, and then phosphorylates Nrf2. PKCδ regulation of NRF2 activity was
determined by PKCδ inhibitor Gö6983 (2 nM). Gö6976 (2 nM), a specific inhibitor of PKCα and PKCβ, did not affect Nrf2 translocation. Casp3
dependent PKCδ activation was tested by Z‐DEVD‐FMK (Z‐DEVD‐F) Casp3 inhibitor (2 nM). DS cultures expressing EV or mCAT were treated
with 200 μM PQ for 48 hr to further increase pNRFser40 nuclear localization and then incubated for 12 hr with inhibitors. *p < 0.05. b and e:
50–60 cells were included in the analysis, for each experimental condition
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inserted into pCAGIG vector in which the green fluorescent protein
(GFP)‐cDNA is under the control of chicken actin‐minimal CMV
(CAG) promoter the resulting plasmids were referred to as shNrf2‐
GFP and shCtrl‐GFP, respectively.
4.4 | Reagents and antibodies
Paraquat (PQ)(Sigma Aldrich) was diluted from a 0.1 M stock prepared
with ultrapure water (Invitrogen). Antibodies for western blotting and
F IGURE 4 Nrf2 prevents critical oxidative damage in DS cells. (a) Inhibition of pNRF2 translocation decreases DS cell proliferation. NL
and DS cells were treated with 2 nM Gö6983 or vehicle for 36 hr and then nuclei were counted. (b) Inhibition of pNRF2 translocation
increases ROS generation. DS cultures expressing EV or mCAT were treated with 2 nM Gö6983 or vehicle for 12 hr and stained with DCF
to measure ROS levels. Cells treated with 2 nM Gö6976 were included as a control. Scale bar = 20 μm. *p < 0.05. (c) Proliferation was
evaluated by BrdU incorporation in NL or DS cultures expressing EV or mCAT. Proliferating cells (BrdU +) over total number of cells (DAPI
+). *p < 0.05. (d) Increased cell area in DS fibroblasts. NL and DS cells expressing EV or mCAT vector were seeded at low density, grown
for 24 hr, fixed and stained with Alexa‐546 Phalloidin and DAPI to visualize cellular an nuclear areas, respectively. Scale bar = 20 μm.
*p < 0.05. a and c: 6 culture replicates (four 10× fields each) analyzed per condition; b: at least 20 cells included in the analysis per
condition; d: 75–80 cells per condition
F IGURE 5 Nrf2 activation is required for DS cell survival. mCAT restores mitochondrial function and suppresses the Nrf2‐mediated
antioxidant response. LEFT PANEL: In DS cells, mitochondrial fragmentation and low MMP (1) are caused by increased ROS production (2)
leading to oxidative damage (3). Under oxidative stress conditions, proteosomal degradation of Nrf2 is inhibited (4) resulting in increased
accumulation of cytoplasmic Nrf2 that, upon PKCδ phosphorylation at serine 40 (5), translocates to the nucleus and activates the expression of
Antioxidant Response Elements (ARE)(6) required for DS cell survival. RIGHT PANEL: In DS cells + mCAT, catalase expression/activity (1) is
sufficient to revert mitochondrial network fragmentation and MMP deficits, reducing ROS (2), minimizing oxidative damage (3), and leading to
Nrf2 proteasomal degradation (4) and inactivation of the now dispensable antioxidant response
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immunocytochemistry: rabbit anti‐catalase (#12980), rabbit anti‐VDAC
(#4866) and rabbit anti‐Caspase 3 (#9662) from Cell Signaling; rabbit
anti‐catalase (sc‐50508), mouse anti‐p53 (sc‐126) and rabbit anti‐Nrf2
(sc‐722) from Santa Cruz; mouse anti‐ATP5α (ab14748) and rabbit anti‐
catalase (ab16731) from Abcam; rabbit anti‐phosphoNrf2ser40 (bs‐
2013R) from Bioss; mouse anti‐ PKCδ (cat #36520) from Transduction
Laboratories; mouse anti‐Tubulin (ATN01) from Cytoeskeleton. Inhibi-
tors: sodium azide from Fisher Scientific; PKCδ (Gö6983), PKCα/β
(Gö6976) and Caspase 3 (Z‐DEVD‐FMK) from Calbiochem. Fluorescent
Dyes: propidium iodide (PI), 2′,7′‐dichlorodihydrofluorescein diacetate
(DCF), tetramethylrhodamine methyl ester perchlorate (TMRM) from
Molecular Probes. Mitochondrial targeted antioxidants: MitoQ, 1 mM
stock in H2O; and MitoTEMPO, 2 mM stock in H2O, from Sigma‐
Aldrich. Nrf2 activators: Oltipraz (Tocris) 5 mM stock in DMSO; Sul-
foraphane (Cayman Chemical), 5 mM stock in ethanol.
4.5 | Mitochondrial network analysis
Quantitative measurement of mitochondrial morphology was per-
formed as described in Zamponi et al., 2018. Briefly, 16‐bit raw pic-
tures were transformed to binary images using an established
threshold value, followed by skeletonization of the binary informa-
tion to obtain an underlying 1 pixel wide structural representation of
the mitochondrial network. Considering the number and identity (de-
gree, see Supporting Information Figure S3) of all the nodes within a
network, mean degree value (MDV) was calculated for each experi-
mental condition. Given that MDV reflects the overall network con-
nectivity, morphological changes in the mitochondrial networks were
estimated by comparing MDV for every condition.
4.6 | Immunoblotting
Cell homogenates were prepared in RIPA buffer and protein concen-
tration was determined by a Lowry‐based assay (DC Protein Assay
Kit, Bio‐Rad). Total protein extracts (30 μg) were mixed with Laemmli
buffer (62.5 mM Tris‐HCl, pH 6.8, 2.3 % SDS, 10% glycerol, 5% β‐
mercaptoethanol, 0.005% bromophenol blue) and boiled for 10 min.
Subsequently, samples were resolved on a 10% SDS‐polyacrylamide
gel and electrotransferred to a polyvinylidene fluoride membrane
(PVDF, Millipore). After blocking overnight at 4°C in TBS‐Tween
0.05% with 5% nonfat dry milk (TBS‐T 5% DM), membranes were
incubated with the appropriate primary antibody diluted 1:1,000 in
TBS‐T 5% DM for 2 hr at room temperature, washed 3 × 10 min
with TBS‐T, then incubated for 2 hr at room temperature with the
corresponding HRP‐conjugated secondary antibody (Jackson Lab)
diluted 1:5,000 in TBS‐T 5% DM and washed 3 × 10 min with TBS‐
T. Protein levels were detected using ECL mix (WesternBright,
Advansta) and radiographic plaques (Fujifilm).
4.7 | Cell fractionation
Cell fractions were obtained as described (Graham, 2001). Briefly,
HEK293 cultures were detached by trypsinization, washed with
Phosphate‐Buffered Saline (PBS) and collected by centrifugation at
800 g for 5 min. Cells were then resuspended in 1 ml of ice‐cold RSB
Hypo buffer (10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris‐HCl, pH = 7.5),
incubated for 10 min in ice and homogenized with 40 strokes in a
1.5 ml glass homogenizer. Immediatly after, homogenized cells were
supplemented with 600 μl of ice‐cold 2.5× Homo buffer (525 mMman-
nitol, 175 mM sucrose, 12.5 mM Tris‐HCl, 2.5 mM EDTA, pH = 7.5)
and 800 μl of 1× Homo buffer, and centrifuged at 200 g for 5 min to
obtain the nuclear fraction. The post nuclear supernatant was then cen-
trifuged at 9,000 g for 15 min to separate the mitochondria‐rich heavy
membrane fraction from the cytosolic fraction. Samples were subse-
quently resolved by immunoblotting, as previously described.
4.8 | Immunocytochemistry
HEK293 cells, MEFs and HFs grown on 12 mm glass coverslips (Car-
olina, Assistant) and treated as indicated in each case, were fixed at
37°C for 20 min with 4% paraformaldehyde‐sucrose solution (PFA).
After that, samples were permeabilized with PBS‐Triton 0.1% for
10 min, blocked with PBS‐Horse Serum (HS, Brand) 10% for 60 min
and incubated over‐night with the appropriate primary antibody,
diluted 1:100 in PBS‐Triton 0.02% with 2% HS. After 6 × 5 min
washes with PBS, coverslips were incubated with the corresponding
Alexa‐conjugated secondary antibody (rabbit/mouse Alexa 488 or
546), diluted 1:500 in PBS‐Triton 0.02% with 2% HS and washed
again 6 × 5 min with PBS. When indicated, samples were also incu-
bated with Alexa‐Phalloidin 546 (1:50 in PBS for 60 min) and DAPI
(1:10,000 in PBS for 1 min). Coverslips were mounted using Fluor-
save (345789‐Millipore) prior to confocal image acquisition.
4.9 | Live‐imaging
For live‐cell imaging of human fibroblasts an Olympus IX81 inverted
microscope was used, equipped with a Disk Spinning Unit (DSU), epi-
fluorescence illumination (150 W Xenon Lamp) and a microprocessor.
Fast image acquisition was achieved with a 60× oil immersion objec-
tive and an ORCA AG CCD Hamamatsu camera. Cells were seeded on
25 mm coversilps 3 days before the experiment, to allow proper
attachment and habituation. Once ready, coverslips were washed with
DMEM without phenol red (DMEMwpr, GIBCO) and incubated for
15 min with the corresponding fluorescent dye (1 μM DCF or 10 nM
TMRM) diluted in DMEMwpr. After this time, coverslips were washed
again and placed on a imaging ring with DMEMwpr, in the conditions
set for the incubator above the microscope platine (37°C and 5%
CO2). Images were acquired over 20 min per coverslip.
For live imaging experiments with HEK cells, a Zeiss Axiovert
200 epifluorescence microscope was employed, equipped with a
10× dry objective and an ORCA II ER Hamamatsu camera. Cells
were seeded on 35 mm plates and treated as indicated in each case,
prior to incubation for 15 min with the corresponding dye (2 μM
DCF or 10 μM TMRM) diluted in DMEMwpr. After washing the
media, plates were placed on an incubator above the microscope
platine at 37°C to proceed with the corresponding image acquisition.
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4.10 | Quantitative real‐time PCR (qPCR)
Total cellular RNA was isolated from HF cultures, using TRIzol
reagent (Thermo‐Fisher). cDNA was prepared using a cDNA Reverse
Transcription kit (Invitrogen). qPCR was performed on a Step OneTM
Real Time PCR System (Applied Biosystems) by SYBR Green Master
Mix reagent detection (Applied Biosystems). The following PCR pri-
mers were used: NQO1 rv: GCAAGTCAGGGAAGCCTGGA; NQO1
fw: GGGCAAGTCCATCCCAACTG; HMOX1 rv: GAGGGGCTCTGG
TCCTTGGT; HOMX1 fw: GGCCTGGCCTTCTTCACCTT; GAPDH rv:
GCCCCAGCGTCAAAGGTGGA; GAPDH fw: ACTGGCGCTGCCAA
GGCTGT. All reactions were performed in triplicate, and the experi-
ments were repeated at least three times.
4.11 | Confocal microscopy
Fixed cells were stained and mounted as explained in the immunocy-
tochemistry section and visualized using an inverted confocal micro-
scope Olympus Fluoview 300.
4.12 | Electroporation
Human fibroblast cultures were washed, detached and centrifuged
as previously described. In each case, 1 × 106 cells were mixed with
2 μg of mitochondrial HyPer (mitoHyPer) along with 2 μg of EV or
mCAT plasmids, and transferred to a 1 ml cuvette. Cells were elec-
troporated using a Nucleofector (Lonza), following manufacturer’s
specifications. Afterwards, electroporated cells were seeded on cov-
erslips, grown for 3 days and fixed with PFA. Mounted samples were
analyzed by confocal imaging.
4.13 | Wound healing assay
HEK cells and human fibroblasts were seeded on a calibrated ibidi
confocal μ‐dish (35mm, glass bottom), and were infected with
pLenti‐eYFP and either pLenti‐EV or pLenti‐mCAT . Once confluent,
growth media was replaced with DMEM without FBS and cultures
were injured with a 0.51 mm‐gauge needle. To discard detached
cells, cultures were washed and fresh growth media was added to
follow wound assay. Images were acquired with a 10× dry objective
every 2 hr for HEK cells, and every 6 hr for human fibroblasts.
4.14 | Catalase activity assay
Catalase activity was measured as previously described described (Iwase
et al., 2013). Briefly, HEK cultures expressing the different plasmids were
washed with PBS, detached by trypsinization and centrifuged (800 g –
5 min). Cell pellets were resuspended in PBS and diluted to an even con-
centration of cell/ml. Afterwards, 100 μl of cell suspention were trans-
ferred to a long, 1 cm diameter tube and mixed with 100 μl of PBS‐
Triton 1% and 100 μl of H2O2 (30 vol). Reaction took place within
5 min, after what the highness of the bubble column was measured as
an indicator of the amount of catalase in the assayed cells.
4.15 | Cell proliferation assay
To analyze the proliferation activity, infected cells were seeded on
12 mm coverslips and incubated with 1:500 Bromodeoxyuridine
(BrdU, Molecular Probes) for 48 hr. Cells were then fixed with ice‐
cold Methanol and immunostained against BrdU and counterstained
with DAPI. Images were acquired in an epifluorescence microscope
with a 10× objective.
4.16 | Image processing
Images were quantified using Fiji (www.fiji.sc). Datasets were ana-
lyzed for significant differences with R (www.r-project.org).
4.17 | Statistical analysis
Experiments including three or more groups were analyzed by one‐
way ANOVA followed by Tukey’s honestly significant difference
(HSD) test. Student’s t test was performed for paired observations.
A value of p < 0.05 was considered statistically significant. Results
were expressed as the mean ± SD. Experiments were repeated at
least three times, using cultures derived from different NL and DS
specimens. Individual experiments were performed in at least tripli-
cate samples.
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